Recent Patents on Drug Delivery & Formulation
Title:Patent Selections
Volume: 11 Issue: 2
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Patent Selections, Recent Patents on Drug Delivery & Formulation 2017; 11 (2) . https://dx.doi.org/10.2174/187221131102171220162928
DOI https://dx.doi.org/10.2174/187221131102171220162928 |
Print ISSN 1872-2113 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4039 |
21
1
1
1
Related Articles
-
Drug Disposition in Pathophysiological Conditions
Current Drug Metabolism Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease
Current Medicinal Chemistry Prediction of Degeneration of Native and Bioprosthetic Aortic Valves:Issue-Related Particularities of Diabetes Mellitus
Infectious Disorders - Drug Targets Thalidomide: An Overview of its Pharmacological Mechanisms of Action
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry In Vitro Synergistic Anti-yeast Activity between Galloyl Derivatives and Amphotericin B
The Natural Products Journal Management of Stable COPD: An Update
Current Respiratory Medicine Reviews Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications
Current Medicinal Chemistry Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy
Current Pharmaceutical Design Coronary Atherosclerosis The Implications of Being a Woman
Current Hypertension Reviews GLUT4 Goes Abnormal: Disregulation of the Insulin-Responsive Glucose Transporter in Abnormal Metabolic States
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Role of Endothelial Progenitor Cell Mobilization After Percutaneous Angioplasty Procedure
Current Pharmaceutical Design Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders
Current Pharmaceutical Design HDL Genetic Defects
Current Pharmaceutical Design The Use of Ghrelin and Ghrelin Receptor Agonists as a Treatment for Animal Models of Disease: Efficacy and Mechanism
Current Pharmaceutical Design Percutaneous Valve Interventions
Current Cardiology Reviews HDL as a Target for Glycemic Control
Current Drug Targets Peptide-Derived Protease-Activated Receptor-1 (PAR-1) Antagonists
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Retinoids: Impact on Adiposity, Lipids and Lipoprotein Metabolism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Inflammation Paradigm and Coronary Artery Disease: What Celsus, Virchow and Gene Knock Outs Have Taught Us
Cardiovascular & Hematological Disorders-Drug Targets